Concepedia

Liaomin Peng

LP

Statistics

Publications

18

Citations

928

H-Index

17

Active since

1997

Affiliations

Cleveland Clinic(Current)

Cleveland Foundation

Novartis (United States)

Roswell Park Comprehensive Cancer Center

Biogen (United States)

Liaomin Peng is an author at Cleveland Clinic specializing in immunology, life sciences, and tumor immunology.

Publications per year

1997–2021

18

Publications

18

Antigen-independent activation enhances the efficacy of 4-1BB-costimulated CD22 CAR T cells

Nathan Singh, Noelle V. Frey, Boris Engels et al. · Nature Medicine · 2021 · 202 citations · Full text

, , +12

CD4+ T Cells in Adoptive Immunotherapy and the Indirect Mechanism of Tumor Rejection

Peter A. Cohen, Liaomin Peng, Gregory E. Plautz et al. · Critical Reviews in Immunology · 2000 · 113 citations

, , +17

Augmentation Versus Inhibition: Effects of Conjunctional OX-40 Receptor Monoclonal Antibody and IL-2 Treatment on Adoptive Immunotherapy of Advanced Tumor

Jørgen Kjærgaard, Liaomin Peng, Peter A. Cohen et al. · The Journal of Immunology · 2001 · 75 citations

, , +15

Treatment of Subcutaneous Tumor with Adoptively Transferred T Cells

Liaomin Peng, Suyu Shu, John C. Krauss · Cellular Immunology · 1997 · 52 citations

, , +13

Monocyte chemoattractant protein inhibits the generation of tumor-reactive T cells.

Liaomin Peng, S Shu, John C. Krauss · PubMed · 1997 · 51 citations

, , +17

1–5 of 18